Anhedonia is the reduced ability to feel pleasure or interest in things that once felt rewarding. It goes beyond being in a funk or feeling bored. A person with anhedonia might understand intellectually that a favorite meal or a reunion with a close friend should be enjoyable yet feel nothing when it happens. The term has been part of psychiatry since the late 1800s, but the science around it has become far more specific in recent years, splitting what seems like a single problem into several distinct breakdowns in how the brain processes reward.
More Than One Kind of Pleasure Problem
Researchers now draw a sharp line between two phases of pleasure. The first is anticipatory pleasure, sometimes called “wanting,” which is the excitement or motivation you feel when looking forward to something good. The second is consummatory pleasure, or “liking,” which is the enjoyment you experience in the moment itself. These two phases rely on partly separate brain systems, and a person can lose one without losing the other.
This distinction matters because it changes what anhedonia actually looks like from one condition to the next. Someone might still enjoy ice cream once it’s in their mouth but feel zero motivation to go get it. Another person might chase rewards eagerly but feel oddly flat when the reward arrives. Research has formalized this split, highlighting how the field has used the term “anhedonia” to describe everything from a long-standing personality trait to a temporary symptom of an acute depressive episode, and these are not the same thing clinically.1PubMed Central. Conceptualizing anhedonias and implications for depression treatments Past studies of anhedonia in conditions like eating disorders, for instance, treated it as a single dimension rather than examining anticipatory and consummatory pleasure separately, which likely masked important differences.2PubMed Central. Anticipatory and consummatory pleasure in eating disorders
What Happens in the Brain
The brain’s reward system isn’t one switch. It’s a network of regions that communicate through chemical messengers, and dopamine gets most of the attention. Dopamine neurons in a deep brain structure called the ventral tegmental area fire when something unexpectedly good happens, or when something expected doesn’t arrive. These “prediction error” signals travel to the striatum and prefrontal cortex, updating your internal sense of what’s worth pursuing. In people with depression, functional connectivity between the ventral tegmental area and the striatum is weaker during reward-related tasks, meaning those prediction error signals don’t get transmitted as robustly.3Neuropsychopharmacology. Impaired reward prediction error encoding and striatal-midbrain connectivity in depression Animal research confirms the striatum’s role: when it’s damaged, dopamine neurons lose the ability to track certain aspects of expected rewards.4PubMed Central. Temporal Specificity of Reward Prediction Errors Signaled by Putative Dopamine Neurons in Rat VTA Depends on Ventral Striatum
Dopamine handles much of the “wanting” side, but the in-the-moment “liking” response involves a different set of chemicals. Opioid and endocannabinoid signals in a tiny region of the nucleus accumbens, sometimes called the hedonic hotspot, amplify the pleasure you feel from something like the taste of sugar. Studies in animals have shown that the endocannabinoid system’s ability to boost that pleasurable reaction depends on opioid signaling in the same area. Block the opioid signal, and the endocannabinoid enhancement disappears.5PubMed Central. Endocannabinoid-Enhanced “Liking” in Nucleus Accumbens Shell Hedonic Hotspot Requires Endogenous Opioid Signals This helps explain why anhedonia can be so stubborn: it’s not just one chemical going wrong but multiple interacting systems.
Neuroimaging in depressed people paints a consistent picture. Compared with healthy individuals, those with depression show weakened communication between the ventral striatum and areas of the prefrontal cortex involved in evaluating rewards, alongside abnormally strong connectivity in circuits associated with cognitive control and rumination.6PubMed Central. Frontostriatal functional connectivity in major depressive disorder The net effect is a brain that has trouble registering that something feels good while simultaneously overthinking everything.
Anhedonia in Depression
Anhedonia is one of the two core symptoms required for a diagnosis of major depressive disorder. It is possible to meet the diagnostic criteria for depression based on anhedonia alone, without persistent sadness. Yet despite this central role, anhedonia appears to be at least partially independent from the broader syndrome of depression. Some people recover from low mood, insomnia, and hopelessness while their ability to experience pleasure remains blunted. A growing body of evidence suggests that anhedonia needs its own targeted assessment and treatment rather than being assumed to improve when depression lifts overall.7PubMed Central. Anhedonia and Depressive Disorders
This independence shows up in treatment outcomes. Standard antidepressants, particularly SSRIs, have limited effectiveness against anhedonia specifically. Some researchers argue this makes sense pharmacologically: SSRIs primarily boost serotonin, which influences mood and anxiety, but the reward circuitry responsible for pleasure relies more heavily on dopamine and opioid signaling. More troublingly, SSRIs can sometimes make anhedonia worse, a phenomenon known as emotional blunting.
When Antidepressants Dull Pleasure Instead of Restoring It
About 45% of patients on antidepressants in one large survey believed their medication was blunting their emotions, and roughly 39% were considering stopping or had already stopped their antidepressant because of this perceived side effect.8PubMed Central. Emotional blunting in patients with depression. Part I: clinical characteristics Emotional blunting doesn’t just dampen sadness. It can flatten positive emotions too, leaving people feeling like they’re watching their life through glass. The experience is described vividly in first-person accounts from people who have cycled through dozens of medications over decades, noting that anhedonia and emotional blunting have, at times, been directly attributable to the treatment itself.9PubMed Central. The Conundrum of Antidepressant-Induced Anhedonia: A Blended Patient-Psychologist Perspective
If you’re on an SSRI and notice that your sadness has improved but you feel weirdly indifferent toward things that used to bring joy, this is worth bringing up with your prescriber. The solution isn’t necessarily to white-knuckle through it. Adjusting the dose, switching to a medication with a different mechanism, or augmenting with an additional agent are all strategies clinicians use to address the problem.
The Schizophrenia Paradox
Anhedonia has long been considered a hallmark “negative symptom” of schizophrenia, but the story is more complicated than it appears. When researchers test people with schizophrenia using pleasant stimuli in the lab, many of them report normal levels of in-the-moment enjoyment. They can taste something sweet, look at a beautiful image, or hear a joke and rate their pleasure as high as anyone else. Where the deficit becomes clear is in anticipatory pleasure: the ability to look forward to something good and feel motivated by that prospect is consistently reduced.10PubMed. Anticipatory pleasure for future rewards is attenuated in patients with schizophrenia but not in individuals with schizotypal traits
This is the “anhedonia paradox” in schizophrenia. People who appear uninterested in pleasurable activities, and who self-report low pleasure on questionnaires, often turn out to enjoy things just fine when those things are placed directly in front of them. The breakdown is in the mental time-travel required to anticipate a future reward and use that anticipation to drive behavior. At least one study, however, found a different pattern, with between-group differences in consummatory rather than anticipatory pleasure, suggesting the picture is still being refined.11PubMed Central. Anticipatory vs. Consummatory Pleasure: What is the Nature of Hedonic Deficits in Schizophrenia? The overall direction of evidence, though, supports the idea that schizophrenia-related anhedonia is primarily a problem of wanting rather than liking.
Social Versus Physical Anhedonia
Another useful distinction is between physical and social anhedonia. Physical anhedonia covers reduced pleasure from sensory experiences: food, music, touch, landscapes. Social anhedonia is the loss of reward from being with people, whether that’s conversation, affection, or shared laughter. These two forms have somewhat different brain signatures. Imaging work has linked them to overlapping but distinct patterns in cortical thickness and subcortical volume, including areas of the frontal cortex and the pallidum.12PubMed. Distinct structural neural patterns of trait physical and social anhedonia: evidence from cortical thickness, subcortical volumes and inter-regional correlations
How these two types map onto clinical conditions is informative. A transdiagnostic meta-analysis found that people with schizophrenia-spectrum disorders endorse greater difficulty experiencing social rewards relative to physical rewards, while people with major depression tend to experience social and physical anhedonia more evenly. In depression, physical anhedonia appears to be more “state-like,” waxing and waning with the severity of the depressive episode, while social anhedonia may be more stable over time.13PubMed. A transdiagnostic meta-analysis of physical and social Anhedonia in major depressive disorder and schizophrenia spectrum disorders
Substance Use and the Reward System Running on Empty
Anhedonia is common during withdrawal from alcohol, cocaine, stimulants, and cannabis. The relationship runs in both directions: people who use substances heavily may do so partly because their baseline capacity for pleasure is low, and heavy use progressively depletes the reward system, deepening the problem. Research has found significant correlations between anhedonia, craving intensity, and the severity of withdrawal symptoms in people with substance dependence. Several researchers have proposed that anhedonia is a key driver of relapse and a factor in the shift from casual use to compulsive drug-seeking.14PubMed Central. Anhedonia and substance dependence: clinical correlates and treatment options
If you’ve ever heard someone in recovery describe the early weeks as flat, gray, and devoid of pleasure, that’s anhedonia. The brain’s reward circuitry was being propped up by the substance, and without it, the circuits need time to recalibrate. Understanding this can make the experience less frightening: it’s a predictable neurobiological process, not evidence that life without the substance will always feel this empty.
Parkinson’s Disease, Stress, and Inflammation
Because dopamine is so central to reward processing, any condition that damages dopamine pathways can produce anhedonia. In Parkinson’s disease, progressive loss of dopamine-producing neurons affects not only motor function but the mesolimbic circuit projecting to the frontal cortex, disrupting the reward system along the way. This contributes to the motivation deficits, social withdrawal, and loss of interest in previously enjoyable activities that many Parkinson’s patients experience alongside the more visible motor symptoms.15PubMed Central. Apathy and Anhedonia in Parkinson’s Disease
Chronic stress is another pathway. Sustained activation of the body’s stress-response system interferes with normal dopamine functioning, impairing reward-related learning in animal models.16PubMed. Investigating dopamine and glucocorticoid systems as underlying mechanisms of anhedonia Early-life adversity may set the stage: rats exposed to stress as pups show reduced preference for sugar water in adolescence, a standard behavioral indicator of anhedonia in animal research.17Biological Psychiatry. Anhedonia Following Early-Life Adversity Involves Aberrant Interaction of Reward and Anxiety Circuits and Is Reversed by Partial Silencing of Amygdala Corticotropin-Releasing Hormone Gene
Inflammation adds yet another layer. The brain circuits and molecular pathways involved in anhedonia, including dopamine transmission, are preferentially affected by inflammatory processes.18PubMed Central. Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression Some researchers have framed this in evolutionary terms: when the immune system detects infection, pulling back from pleasurable activities like socializing and exploring conserves energy for fighting the pathogen. The behavioral withdrawal we call “sickness behavior” shares features with anhedonia and may have provided a survival advantage in ancestral environments where infection was a constant threat.19PubMed Central. The role of inflammation in depression: from evolutionary imperative to modern treatment target The trouble arises when this response persists long after the infection is gone, or when chronic low-grade inflammation keeps the system switched on.
How Anhedonia Gets Measured
If anhedonia is this multifaceted, measuring it reliably is a challenge. The most widely used tool in clinical settings is the Snaith-Hamilton Pleasure Scale, or SHAPS, a brief questionnaire asking about enjoyment of everyday experiences like a favorite food, seeing smiling faces, or smelling flowers. Validation studies have found it to be a reliable instrument for assessing positive emotional experience in adults with depression, with certain items, such as those tapping basic sensory pleasures, providing more information about the underlying trait than others.20PubMed Central. Evaluation of Anhedonia with the Snaith–Hamilton Pleasure Scale (SHAPS) in adult outpatients with major depressive disorder21PubMed Central. Measuring Anhedonia in Adolescents: A Psychometric Analysis
A newer alternative, the Dimensional Anhedonia Rating Scale (DARS), takes a different approach. Instead of a single score, it breaks anhedonia into four domains: hobbies, sensory experiences, social interaction, and food. Compared with the SHAPS, the DARS captures about 73% of the variation in responses versus 48% for the SHAPS, suggesting it picks up subtler differences. The two scales correlate only moderately with each other, indicating they’re measuring somewhat different facets of the same broad problem. The DARS may be particularly useful for detecting nuanced hedonic deficits in non-clinical populations, while the SHAPS remains a practical choice in clinical settings where brevity matters.22PubMed. The snaith-hamilton pleasure scale (SHAPS) and dimensional anhedonia rating scale (DARS) diverge in measuring anhedonia in a community sample of young adults
What Treatments Actually Help
Given that standard SSRIs are limited in addressing anhedonia, what works better? Several medications with different mechanisms show more promising anti-anhedonic effects. Vortioxetine, agomelatine, bupropion, brexpiprazole, and ketamine have all demonstrated stronger results than SSRIs in reducing anhedonia.23PubMed Central. Anhedonia: Current and future treatments Ketamine, in particular, has drawn attention because of its speed. In a placebo-controlled trial involving people with treatment-resistant bipolar depression, a single intravenous ketamine infusion significantly reduced anhedonia at multiple time points over the following two weeks.24Translational Psychiatry. Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression This is striking because anhedonia in treatment-resistant cases is, almost by definition, the symptom that hasn’t responded to the medications already tried.
Psychotherapy also plays a role, and behavioral activation stands out. The logic is straightforward: when anhedonia saps your motivation, you stop doing things, which removes opportunities for positive experience, which deepens the anhedonia. Behavioral activation works by scheduling activities linked to your values and gradually re-engaging with them even when motivation is low. Combining behavioral activation with transcranial magnetic stimulation in one pilot study produced an average 39% reduction in SHAPS anhedonia scores alongside broader improvements in depression.25PubMed. Behavioral activation therapy during transcranial magnetic stimulation for major depressive disorder The combination approach is still being studied, but the early data suggest that pairing a brain-stimulation technique targeting the reward circuit with a behavioral strategy designed to re-engage with rewards may be more effective than either alone.
Tracking Anhedonia in Real Time
One of the frustrations with treating anhedonia is that it’s difficult to monitor between appointments. You might not remember exactly how flat you felt three Tuesdays ago. Researchers are beginning to use smartphones to fill this gap. In a proof-of-concept study with adolescents receiving behavioral activation therapy for anhedonia, participants completed brief daily check-ins on their phones reporting on mood and activities. An AI model rated how “activated” their free-text diary entries sounded, and a subset of participants contributed passive sensor data from their phones, things like how many places they visited and how much time they spent away from home. Higher AI-rated activation tracked with better daily mood, and the passive sensor data predicted weekly improvements in anhedonia scores.26PubMed Central. Measuring activation during behavioral activation therapy: a proof-of-concept study using smartphone sensors and LLM-derived ratings in adolescents with anhedonia
This kind of real-time tracking is still experimental, but the direction is promising. If a phone can detect early signs that someone is withdrawing from activities and becoming more sedentary, a clinician could intervene earlier rather than waiting for the next scheduled visit. For a symptom as insidious as anhedonia, where the person affected often lacks the motivation to flag the problem themselves, any tool that makes the invisible visible has real potential.
Why Animal Models Are Harder Than They Look
Much of what we know about the brain mechanisms underlying anhedonia comes from animal research, especially models using chronic mild stress in rodents and then measuring whether the animals lose their preference for sugar water. This sucrose preference test is widely used as an analog for human anhedonia, but it has real limitations. Not all labs can replicate the key effect, and it remains unclear how closely a rat’s reduced interest in sugar corresponds to a person’s inability to enjoy music, laughter, or a sense of accomplishment.27PubMed Central. Sucrose Preference Test as a Measure of Anhedonic Behavior in a Chronic Unpredictable Mild Stress Model of Depression: Outstanding Issues Human anhedonia encompasses social, aesthetic, and cognitive pleasures that have no obvious rodent equivalent. The animal work has been invaluable for identifying candidate brain circuits and neurotransmitter systems, but translating those findings into treatments that work in people has been slower than anyone hoped.